Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.934 USD | +9.89% | +38.15% | -2.81% |
14/05 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
13/05 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.81% | 30.55M | |
-29.00% | 70.3B | |
+2.04% | 27.46B | |
-6.29% | 17.8B | |
+2.32% | 17.46B | |
+1.91% | 15.46B | |
+6.88% | 13.49B | |
+10.80% | 13.06B | |
+70.98% | 12.96B | |
+75.31% | 12.56B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Earnings Flash (XGN) EXAGEN Posts Q4 Loss $-0.42, vs. Street Est of $-0.46